Emerging Approaches to Improving Adoptive Cell Therapy


Flow cytometry with CyTOF is enabling improved profiling of CAR cell products and their functional characteristics.

This mini-symposium brought together investigators taking innovative approaches to address these challenges. The expert research presented spans diverse aspects of CAR cell therapeutic development, from expanding our understanding of immune cell function to improving CAR T manufacturing to monitoring CAR cells in clinical research trials.


Publications Trending Now:
A compilation of recent research on CAR T and CAR NK cells using high-content cytometry with CyTOF®

Download
Using CyTOF for CAR T analysis:
A Streamlined Research Assay for Longitudinal Immune Monitoring of Cellular Therapies

Download
 
Topics and Speakers  

» Expanding CAR T cell profiling to accelerate therapeutic insights

Greg Hopkins, PhD

Greg Hopkins
Associate Manager, Scientist, 2seventy bio

Watch video

 

» Understanding the metabolic dynamics of T cells and CAR T cells from single-cell data

Matthew Spitzer, PhD

Matthew Spitzer, PhD
Assistant Professor, University of California San Francisco (UCSF)

Watch video

 

» Introducing CyTOF® XT and Maxpar™ Direct™ Assays for efficient high-content immune profiling

Emily Thrash, PhD

Emily Thrash, PhD
Field Application Specialist Proteomics, Fluidigm

Watch video

 

» Mass cytometry: A robust platform for the comprehensive immunomonitoring of CAR T cell therapies

Damien Roos-Weil, MD

Jonathan Caron, PhD
Researcher, Assistance Publique – Hôpitaux de Paris

Watch video

 

» Interrogating CAR T cell spatiotemporal plasticity 

Damien Roos-Weil, MD

Lior Goldberg, MD
Pediatric Oncologist, Physician-Scientist, City of Hope Comprehensive Cancer Center 

Watch video

 



Unless explicitly and expressly stated otherwise, all products are provided for Research Use Only, not for use in diagnostic procedures. Find more information here.